Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sage Therapeutics Inc.

    NASDAQ: SAGE · Real-Time Price · USD
    8.68
    0.00 (0.00%)
    At close: Jul 30, 2025, 3:59 PM

    Sage Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 41.24M 86.45M 7.69M 6.31M
    Cost of Revenue
    		 9.44M 2.16M 813K 553K
    Gross Profit
    		 31.8M 84.3M 6.87M 5.75M
    Operating Income
    		 -432.37M -579.85M -546.99M -460.91M
    Interest Income
    		 31.68M 38.74M 14.19M 2.88M
    Pretax Income
    		 -400.67M -541.49M -532.78M -457.89M
    Net Income
    		 -400.67M -541.49M -503.27M -450.83M
    Selling & General & Admin
    		 216.42M 274.52M 227.7M 183.5M
    Research & Development
    		 225.9M 356.24M 326.16M 283.17M
    Other Expenses
    		 21.85M 33.39M 15K 134K
    Operating Expenses
    		 464.17M 630.76M 553.86M 466.66M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 473.61M 666.69M 554.67M 467.22M
    Income Tax Expense
    		 n/a n/a -29.52M -7.07M
    Shares Outstanding (Basic)
    		 60.77M 59.84M 59.31M 58.67M
    Shares Outstanding (Diluted)
    		 60.77M 59.84M 59.31M 58.67M
    EPS (Basic)
    		 -6.59 -9.05 -8.49 -7.68
    EPS (Diluted)
    		 -6.59 -9.05 -8.49 -7.68
    EBITDA
    		 -409.49M -545.07M -545.87M -456.73M
    EBIT
    		 -410.52M -546.46M -546.99M -460.91M
    Depreciation & Amortization
    		 1.03M 1.39M 1.12M 4.18M

    Add to Watchlist